Last updated on June 2017

Low to Intermediate-Risk Prostate Cancer


Brief description of study

Low to Intermediate-Risk Prostate Cancer

Detailed Study Description

A Multi-Center, Open Label, Phase 2b study, Evaluating the safety, tolerability and efficacy of Targeted Intraprostatic Administration of XXXXX to treat men with histologically proven, clinically significant, localized, Low-to Intermediate-Risk Prostate Cancer that is associated with an MRI Leasion

Clinical Study Identifier: TX150683

Find a site near you

Start Over

South Florida Medical Research

21150 Biscayne Blvd. Suite #300 Aventura, FL USA
  Connect »